Home LiteratureArticle Details
PMID: 24191246 Published · ppublish English

Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5.

BioMed research international ·Vol. 2013 ·2014-06-09

Han Xiu-juan, Xue Li, Gong Li, Zhu Shao-jun, Yao Li, Wang Shu-mei, Lan Miao, Zhang Wei, Li Yan-hong

Abstract

Proteins of the protein tyrosine phosphatase (PTP) family are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, and apoptosis. PTPN13 (also known as FAP1, PTPL1, PTPLE, PTPBAS, and PTP1E), a putative tumor suppressor, is frequently inactivated in lung carcinoma through the loss of either mRNA or protein expression. However, the molecular mechanisms underlying its dysregulation have not been fully explored. Interleukin-6 (IL-6) mediated Stat3 activation is viewed as crucial for multiple tumor growth and progression. Here, we demonstrate that PTPN13 is a direct transcriptional target of Stat3 in the squamous cell lung carcinoma. Our data show that IL-6 administration or transfection of a constitutively activated Stat3 in HCC-1588 and SK-MES-1 cells inhibits PTPN13 mRNA transcription. Using luciferase reporter and ChIP assays, we show that Stat3 binds to the promoter region of PTPN13 and promotes its activity through recruiting HDAC5. Thus, our results suggest a previously unknown Stat3-PTPN13 molecular network controlling squamous cell lung carcinoma development.

Article Info
Journal
BioMed research international
Abbr.
Biomed Res Int
ISSN
2314-6141
Published
2014-06-09
Indexed
2013-11-05
Updated
2015-04-22
Language
English
Country/Region
United States
NLM ID
101600173
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]